This Nvidia Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

  • Redburn Atlantic analyst Timm Schulze-Melander initiated coverage on NVIDIA Corporation NVDA with a Buy rating and announced a price target of $178. Nvidia shares closed at $145.26 on Monday. See how other analysts view this stock.
  • Benchmark analyst Matthew Harrigan initiated coverage on VEON Ltd. VEON with a Buy rating and announced a price target of $48. VEON shares closed at $33.17 on Monday. See how other analysts view this stock.
  • UBS analyst Eliana Merle initiated coverage on Altimmune, Inc. ALT with a Buy rating and announced a price target of $26. Altimmune shares closed at $7.35 on Monday. See how other analysts view this stock.
  • Capital One analyst Dan Guglielmo initiated coverage on FrontView REIT, Inc. FVR with an Overweight rating and announced a price target of $22. FrontView REIT shares closed at $18.97 on Monday. See how other analysts view this stock.
  • UBS analyst Eliana Merle initiated coverage on Sagimet Biosciences Inc. SGMT with a Buy rating and announced a price target of $12. Sagimet Biosciences shares closed at $5.85 on Monday. See how other analysts view this stock.

Considering buying NVDA stock? Here’s what analysts think:

Read More:

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: NewsInitiationMarketsAnalyst RatingsTrading IdeasTop Initiations
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!